- Singular Health’s (SHG) 25 per cent interest company, Additive Engineering (AE) has successfully commissioned a manufacturing facility in Melbourne, which is now commercially operational
- The facility has 3D printers and is fully integrated for on-site design and manufacture
- An initial print job has produced a titanium cutting guide and delivered first revenues to AE
- The company entered into a production sharing agreement with Device Technologies, which will see it give preferential access to the facility in exchange for promotion of its services
- Shares are trading flat today at 21 cents
Medical technology company Singular Health’s (SHG) 25 per cent interest company, Additive Engineering (AE) has successfully commissioned a manufacturing facility in Melbourne, which is now commercially operational.
The facility has had three 3D titanium printers and two polymer 3D printers installed. It is fully integrated for on-site design and manufacture, with a mezzanine office.
An initial print job has produced a titanium cutting guide and delivered first revenues to AE.
The company entered into a production sharing agreement with medical technology provider Device Technologies.
Device Technologies will have preferential access to the facility in exchange for promotion and re-selling of AE’s services.
Singular Health CEO Thomas Hanly said the company’s investment in AE will provide it with significant benefits.
“Access to advanced manufacturing capabilities, including 3D printing, is an essential part of Singular Health’s Scan to Surgery process and is the last step prior to the surgery itself,” he said.
“The workflows used by Additive Engineering demonstrates the commercial and clinical viability of the patient-specific implant design and print process.
“We are very excited to see our investment come to fruition in just 11 months with the commissioning and first print now completed.”
Shares were trading flat today at 21 cents at 3:15 pm AEDT.